CYTK Cytokinetics Inc

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

$19.39  -0.29 (-1.47%)
As of 03/08/2021 10:17:58 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
04/29/2004
71,110,576
938,410
$1,399,456,136
0.00%
SEC Edgar Online
10-Q
10-K
23282W605
US23282W6057
BBBSBJ5

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-10.99
12.32
25.07
-112.27%
-228.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy